The NeVap Mission
NeVap, Inc. addresses critical unmet clinical needs with innovative medical devices, dedicated to lowering critical care costs and saving precious lives.
The NeVap ASSET
The NeVap Aspire Subglottic Suction Endotracheal Tube (ASSET) evacuates secretions through a patented, multiport vacuum appendage. This appendage provides unobstructed suctioning away from the trachea wall to accommodate a wide range of patient positioning. In addition, the appendage is radiopacity enables fluoroscopic visualization to facilitate proper user placement.
Please take a look at the endotracheal tube comparison below. The team added 10ml of thick fluids to mimic secretions seen in the trachea, then compared the rate of recovery for the NeVap ASSET (Right) and the industry standard single port Subglottic Suction Endotracheal tube. Both devices were set to 100mm hg suctioning and cuff inflation was continuously monitored and held at 25mm H2O.
The Competing ET Tube The NeVap ASSET
Behind every success is a strong team. The NeVap Management Team covers all bases when it comes to medical devices. From a medical device executive to a FDA compliance expert, the team works to ensure that the NeVap product is successfully launched in hospitals around the Bay Area. Brenton Hanlon is Chair and CEO…
Our Advisory Board guides the NeVap Management Team through every success and challenge. With skillsets and experience in both breadth and depth, the Advisory Board provides valuable advice in all matters surrounding our product’s development, market, production, and more. Lorin Johnson, Ph.D. is the Founder and Chief Scientist of Glycyx Pharma Ventures, a Life Science…